Table 4.
Beta coefficients (SE; p-value) and weights assigned to quartile scores, for association with ALT, separate models for each analyte class, NHANES 2003–2004.
| Analyte | Unweighted quartile score | Weighted quartile score |
|---|---|---|
| Metals (ug/mL serum) | −0.007 (0.007; 0.30) | 0.02 (0.01; 0.04) |
| Cadmium | -- | 0 |
| Lead | -- | 0 |
| Mercury | -- | 1 |
| Dioxin-like compounds (ng/g lipid) | −0.003 (0.002; 0.21) | 0.05 (0.02; 0.009) |
| PCB 28 | -- | 0 |
| PCB 66 | -- | 0 |
| PCB 74 | -- | 0 |
| PCB 105 | -- | 0 |
| PCB 118 | -- | 0 |
| PCB 156 | -- | 0 |
| 1,2,3, 6,7,8-HXCDD | -- | 0 |
| 1,2,3,4,6,7,8-HPCDD | -- | 0.30 |
| 1,2,3,4,6,7,8,9-OCDD | -- | 0 |
| 1,2,3,4,6,7,8-HPCDF | -- | 0 |
| 3,3',4,4',5-PNCB | -- | 0.70 |
| Non-dioxin-like PCBs (ng/g lipid) | 0.0006 (0.001; 0.64) | 0.05 (0.02; 0.03) |
| PCB 44 | -- | 0 |
| PCB 49 | -- | 0 |
| PCB 52 | -- | 0 |
| PCB 87 | -- | 0 |
| PCB 99 | -- | 0 |
| PCB 101 | -- | 0.10 |
| PCB 110 | -- | 0 |
| PCB 138 | -- | 0 |
| PCB 146 | -- | 0 |
| PCB 149 | -- | 0 |
| PCB 151 | -- | 0 |
| PCB 153 | -- | 0 |
| PCB 170 | -- | 0 |
| PCB 177 | -- | 0 |
| PCB 178 | -- | 0 |
| PCB 180 | -- | 0.04 |
| PCB 183 | -- | 0 |
| PCB 187 | -- | 0.86 |
| PCB 194 | -- | 0 |
| PCB 196 | -- | 0 |
| PCB 199 | -- | 0 |
| PCB 206 | -- | 0 |
| PCB 209 | -- | 0 |
*
Adjusted for sex, race/ethnicity, poverty-income ratio (continuous), age (continuous), and BMI (continuous)